23-24 years old
10 Months. Full Time
October 2022 - Applications Open
None to 2 years
94% of the students within the year
> 15 Nationalities
The objective of the programme is to acquire a deep understanding of the key aspects of the processes involved in the set-up of biotechnology-based companies, fundraising with private equity to develop the drug candidate, and the relationships between global departments of the pharmaceutical industry in order to develop later stages of clinical trials.
The main roles in companies related to these areas of knowledge are those such as: investment analyst, innovation science liaison, project leader, business development, financial consultant among other corporate positions at biotechnology-based companies or the pharmaceutical industry and other companies related to healthcare.
The main areas of work and topics are related with corporate management, entrepreneurship and innovation, financial valuations in biotech markets, venture funding and private equity and international business development in the life sciences sector.
The BBI MBAs and Executive Programmes give the students applied knowledge about the Biotechnology sector beyond the laboratory, opening a new wide range of professional development and career opportunities
Esther Riambau - Life Science Director at UPF Ventures
We motivate entrepreneurship and innovation in Life Sciences. The students will not only acquire theoretical knowledge throughout the course, but also become an active part of the sector from the first day
William Hariri – Vice President at Locust Walk
The master's programs cover a growing unsatisfied necessity for scientific profiles that want to orient the professional career towards management, business and investment in applied research
Mireia Angulo - Senior Investment Analyst at Caixa Capital Risk
The greatest thing is that all the Alumni are now part of the Biotech and Pharma sector, each of us growing in our own way and still doing science.
Beatriz Volckaert - Impact Investment Analyst at Ship2B & BBI Alumni
Acquiring a global perspective of capital markets in biotechnology and understanding the investment analysis process, is a crucial step towards a financial career development in private equity and corporate management in biotechnology venture funds
Guillem Laporta - Principal at Ysios Capital
Here are some of the most frequent questions from our candidates
With a presence in two of the main innovation centres in Europe, Barcelona and Cambridge, our students can choose which campus will best meet their needs. The Barcelona Campus focuses on Drug Discovery, which is central to future career progression in pharmaceutical and biotechnology companies.
The newer Cambridge Campus has a broader remit across the entire Life Science sector. At Cambridge, UK, our students can realise their objective of establishing a global network of contacts in the broader spectrum of commercial opportunities in Life Sciences.
The BBI Business School has over 140 academics and industry experts, coming from more than 20 countries, who cover the key management topics in the Life Sciences industry: corporate finance; market access and healthcare economics, preclinical and clinical regulatory requirements, medical technologies, technology transfer and entrepreneurship, organisational behaviour and an understanding of the global strategy for new drug approvals.
The Biotechnology Business Institute (BBI) is an international business school focused on training a new generation of scientific managers and executives to prepare for their future careers. The BBI facilitates early-stage business development activities in partnership with the many stakeholders in the biotechnology sector and the pharmaceutical industry worldwide. A core focus is on new drug development to treat unmet medical need but also with broadening interests across the Life Sciences sector.
The Biotechnology Business Institute was founded to develop the next generation of talent in the international Life Sciences sector for scientists seeking to advance their careers in the pharmaceutical and biotechnology industries. We are committed to becoming a leading international academic institution in the management of Life Sciences, through enabling the career development of a new wave of global business leaders driving disruptive change throughout the ecosystem.
Our complementary MBA programmes in Biotechnology and in Life Sciences enable scientists to enter this growing industrial sector each year. We help our students develop a clear vision of their career progression into future leadership roles. By using the new skills and practical experiences from our courses, our alumni go on to join the some of the most notable institutions, companies and national healthcare systems with international reputations.
Every day is different throughout the year. During the first stage, when students take their common modules, apart from the evening classes from Monday to Thursday, the students also develop their career impact programmes. These programmes have their project meetings at various research centres and participate in extra-curriculum activities.
For the final semester in Barcelona, each student develops their own academic internship programme depending on their chosen career itinerary chosen. All programmes have the same number of assignments and group work to complete. Typically, the second semester is focused increasing the time spent on students’ career-related activities.
Thanks to our unique educational agreement with three of the main research centres in Barcelona our model, based on a practical patent filings, that allows our students to have an intensive full-time experience to achieve a global understanding of commercial decision-making processes.
Discussions with principal researchers and innovation managers who are planning on developing new drugs make this experience very interactive and with the academic co-ordination and the board of lectures further discussion are continued during the practical classes. The case study case is a real example, reflecting today’s global business ecosystem in biotechnology and the pharmaceutical industry.
For more information, visit our BBI community Report
BBI MBA students have an average age of 24, although a few students may be slightly older. In some cases, other BBI programmes such our Executive Education courses are recommended as they may be a better fit for some specific professional goals. However, there is no upper age limit and all ages are encouraged to apply.
Our career opportunities are similar for whatever career path you may choose, nevertheless, the differing itineraries may take you along different career paths. Before deciding what itinerary you may choose, you may need to have during the admission process a career pre-assessment evaluation. In addition, when you start an MBA course in October you will be working with our Career Specialists team to enable your next career step from the beginning of the academic year.
No. English is the language of instruction on both campuses.
The MBA has a general management focus with the objective of preparing leaders to take on global roles in organisations or start their own companies a near future. In addition, students can concentrate on a particular area by taking different itineraries, which are offered during the second semester.
Yes, studying for an International MBA is a key step forwards in your more commercial career progression in industry after your PhD. The transition from the research laboratory into new management positions requires an understanding of many additional business aspects for the effective commercialisation of scientific research. For example, developing new products and treatments requires an in-depth understanding of how the pharmaceutical industry, as well as biotechnology, medial devices and digital health companies, operate commercially.
The BBI MBA syllabus or curriculum is prepared to deliver a one-year more intensive approach to a professional development in international business administration specifically relevant for the biotechnology sector and the pharmaceutical industry. The return on your investment after completing the MBA is relatively rapid due to our career impact programme and the development of your personal skills to manage your time and make decisions more efficiently.
Applying to this MBA programme will challenge your leadership business skills and develop them to the highest level in a specific sector. Unlike other MBAs, we focus only on one industrial sector and do not dilute your time by teaching on other less relevant sectors to you career.
The BBI students during the MBA programme reside full-time in Barcelona, attending classes Monday through Thursday, and a different variety of networking activities and conferences take place during the year.
MBA students tend to be at an earlier stage in their careers and have less professional experience than participants in the Executive Programmes. The majority of participants in the Executive Programmes are already working industry and continue to work while they carry out the programme in parallel.
We understand the initial step that scientists need to make to develop their future professional development in business, it will not impact your chances of acceptance if you do not have experience in- company as yet. At the BBI we value students driven by their commercial objectives and with a clear mindset in terms of personal and future professional development.
We welcome all applications and we receive many different types of applications. We expect the same from all candidates, which is a strong willingness to develop their management skills towards making a difference the global industry and to demonstrate their leadership potential. Business acumen can be developed but the motivation needs to come from the student.
We cannot define a typical profile of a student at the BBI. We have a very diverse set of students every year in terms of age, professional experience, education and culture. Review the latest alumni report for further information.
Yes. All applications go through a first process of selection where the candidate will be interviewed to assess the application, review the programme objectives and understand the potential of the BBI career impact programme on their careers. After this first stage, only those selected from the interview will continue with the application process. Interviews can be via videoconference, especially during the COVID-19 pandemic.
The different career “itineraries” will take you through the relevant specialisations in the global industry to develop your future career. The main aspect of this process is to help you decide how this could help develop your future career path.
The BBI has an international assessment programme for the students to help them understand how to development their career paths into suitable companies. Contact us at firstname.lastname@example.org